AMERICAN INDUSTRIAL PARTNERS COMPLETES ACQUISITION OF AGCO'S GRAIN & PROTEIN BUSINESS
Get Alerts AGCO Hot Sheet
Join SI Premium – FREE
Rebranded Grain & Protein Technologies, the new standalone entity will be led by accomplished industrial manufacturing leader
Serving customers in over 100 countries worldwide, Grain & Protein Technologies employs more than 3,200 people across its 14 manufacturing facilities in
"I am delighted to be partnering with AIP again, and whole-heartedly believe in the potential for value creation of this great group of businesses that have an important purpose of Feeding the World Better," said
Sidley Austin LLP served as legal counsel to AIP. Morgan Stanley & Co. LLC and Rabo Securities USA, Inc. served as financial advisors to AGCO. Santander US Capital Markets LLC served as financial advisor to AIP and its affiliate led the fully committed debt financing. Simpson Thacher & Bartlett LLP served as legal advisor to AGCO.
About American Industrial Partners
American Industrial Partners ("AIP") is an industrials investor, with approximately
About AGCO
AGCO (NYSE: AGCO) is a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology. AGCO delivers value to farmers and OEM customers through its differentiated brand portfolio including core brands like Fendt®, GSI®, Massey Ferguson®, PTx and Valtra®. AGCO's full line of equipment, smart farming solutions and services helps farmers sustainably feed our world. Founded in 1990 and headquartered in Duluth,
Contacts:
Media Inquiries: American Industrial Partners – [email protected]
Media inquiries: AGCO –
Investor inquiries: AGCO –
View original content:https://www.prnewswire.com/news-releases/american-industrial-partners-completes-acquisition-of-agcos-grain--protein-business-302294121.html
SOURCE American Industrial Partners
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lloyds Energy Ltd Announces Strategic Evaluation of LNG and Regasification Opportunities Across Emerging Energy Markets
- Press Release: Sanofi’s Wayrilz approved in Japan to treat immune thrombocytopenia
- Breakthrough At-Home Vision Testing Platform Reinvents the Eye Exam with MIT Science and Telehealth
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Morgan Stanley, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share